![]() |
New to the Huntington's Disease Lighthouse? |
||
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home \ Research \ General Research \ Updates
|
||||||||||||||||||||||||
|
HD Lighthouse Editor's Comment: The powerful resources of the cancer research community are now focused on Huntington's disease because the expanded huntingtin gene protects against cancer. This could be a fast track to new treatments for both cancer and HD.
The expression of the newly discovered Poly-Q Enhancer (PQE) gene protects a worm against Huntington's disease. We can expect PQE genes to be found in humans. This will open new paths to the treatment of HD. --Jerry
Glutamine/proline-rich PQE-1 proteins protect Caenorhabditis elegans neurons from huntingtin polyglutamine neurotoxicity.Huntington's disease is a progressive neurodegenerative disease caused by a polyglutamine (polyQ) repeat expansion in the huntingtin protein [Huntington's Disease Collaborative Research Group (1993) Cell 72, 971-983]. To understand the mechanism by which polyQ repeats cause neurodegeneration and cell death, we modeled polyQ neurotoxicity in Caenorhabditis elegans. In our model, expression of N-terminal fragments of human huntingtin causes polyQ-dependent degeneration of neurons. We conducted a genetic screen to identify proteins that protect neurons from the toxic effects of expanded polyQ tracts. Loss of polyQ enhancer-1 (pqe-1) gene function strongly and specifically exacerbates neurodegeneration and cell death, whereas overexpression of a pqe-1 cDNA protects C. elegans neurons from the toxic effects of expanded huntingtin fragments. A glutamine/proline-rich domain, along with a charged domain, is critical for PQE-1 protein function. Analysis of PQE-1 suggests that proteins exist that specifically protect neurons from the toxic effects of expanded polyQ disease proteins. Source: Proc Natl Acad Sci U S A 2002 Dec 16;
|
|
|||||||||||||||||||||||
| Disclaimer & Privacy
Policy | |
|